Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

• Aimaz Afrough,
• Hamza Hashmi,
• Doris K. Hansen,
• Surbhi Sidana,
• Chul Ahn,
• Lauren C. Peres,
• Danai Dima,
• Ciara L. Freeman,
• Omar Castaneda Puglianini,
• Mehmet H. Kocoglu,
• Shebli Atrash,
• Peter M. Voorhees,
• Leyla Shune,
• Joseph P. McGuirk,
• Gary Simmons,
• Douglas W. Sborov,
• James A. Davis,
• Gurbakhash Kaur,
• Aishwarya Sannareddy,
• Christopher J. Ferreri,
• Mahmoud R. Gaballa,
• Scott Goldsmith,
• Omar Nadeem,
• Shonali Midha,
• Charlotte B. Wagner,
• Frederick L. Locke,
• Krina K. Patel,
• Jack Khouri,
• Larry D. Anderson,
• Yi Lin

Affiliations

Aimaz Afrough

Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Hamza Hashmi

Medical University of South Carolina

Doris K. Hansen

H. Lee Moffitt Cancer Center & Research Institute

Surbhi Sidana

Stanford University School of Medicine

Chul Ahn

Peter O’Donnell Jr. School of Public Health, UT Southwestern Medical Center

Lauren C. Peres

H. Lee Moffitt Cancer Center & Research Institute

Danai Dima

Cleveland Clinic Taussig Cancer Center

Ciara L. Freeman

H. Lee Moffitt Cancer Center & Research Institute

Omar Castaneda Puglianini

H. Lee Moffitt Cancer Center & Research Institute

Mehmet H. Kocoglu

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Shebli Atrash

Levine Cancer Institute

Peter M. Voorhees

Levine Cancer Institute

Leyla Shune

The University of Kansas Medical Center

Joseph P. McGuirk

The University of Kansas Medical Center

Gary Simmons

Virginia Commonwealth University Massey Cancer Center

Douglas W. Sborov

The University of Utah Huntsman Cancer Institute

James A. Davis

Medical University of South Carolina

Gurbakhash Kaur

Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Aishwarya Sannareddy

Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Christopher J. Ferreri

The University of Texas MD Anderson Cancer Center

Mahmoud R. Gaballa

The University of Texas MD Anderson Cancer Center

Scott Goldsmith

City of Hope National Medical Center

Omar Nadeem

Dana-Farber Cancer Institute

Shonali Midha

Dana-Farber Cancer Institute

Charlotte B. Wagner

The University of Utah Huntsman Cancer Institute

Frederick L. Locke

H. Lee Moffitt Cancer Center & Research Institute

Krina K. Patel

The University of Texas MD Anderson Cancer Center

Jack Khouri

Cleveland Clinic Taussig Cancer Center

Larry D. Anderson

Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Yi Lin

Mayo Clinic